<DOC>
	<DOCNO>NCT00797550</DOCNO>
	<brief_summary>The hypothesis Aastrom TRC autologous bone marrow tissue `` graft '' safely use promote bone heal part single level posterolateral spine fusion surgical procedure .</brief_summary>
	<brief_title>Use TRC Autologous Bone Marrow Cells Posterolateral Lumbar Spine Fusion</brief_title>
	<detailed_description />
	<criteria>Adults , 1875 year age Identified eligible elective surgery single ( 1 ) level , posterolateral spinal fusion L1 S1 spine stabilization accomplish pedicle screw rod . Male patient female patient ( pregnant lactating ) . Patients use appropriate form contraception participate study . Patients able give inform consent . Normal organ marrow function Patients hypophosphatasia , primary secondary hyperparathyroidism cause chronic renal insufficiency osteomalacia . Patients osteoporotic vertebral fracture . Patients prior spinal fusion level treat . Concomitant use BMP , device contain BMP , electronic growth stimulators . Any active infection clinical significance exclude study . Positive HIV , HTLV and/or syphilis . Active Hepatitis B , Hepatitis C infection time enrollment . Known allergy protein product ( horse bovine serum , porcine trypsin ) use exvivo cell production process . Patients require systemic corticosteroid therapy surgery . Pregnancy lactation ; positive hCG . Body Mass Index ( BMI ) 40 Kg/m2 great . Patients unable tolerate general anesthesia define ASA criterion &gt; 2 . Patients poorly control diabetes mellitus ( HbA1C &gt; 7 % ) . Rationale Exclusion Certain Study Candidates 1 . Patients diseases excluded avoid confound factor might impact evaluation safety efficacy TRC cell therapy posterolateral spine fusion . 2 . More extensive surgery require one ( 1 ) level fusion contraindicate study , avoid confound factor might impact evaluation safety efficacy TRC cell therapy . In opinion investigator , patient unsuitable cellular therapy unable continue study . Patients drink 2 alcoholic drink per day history illicit drug use time enrollment shall enrol study . Patient know noneuthyroid baseline . Patients undergo active cancer therapy . Bisphosphonate Therapy 1 . Patients undergone bisphosphonate therapy within last 10 year . 2 . Initiation bisphosphonate therapy patient study prohibit . Patients know diagnosis osteoporosis record BMD le 2.5 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>posterolateral spine fusion</keyword>
	<keyword>bone graft</keyword>
</DOC>